Clin2
NCT06907498Possibly a fitRecruiting

Comparing two drugs for Dientamoeba fragilis stomach issues

Dientamoeba Fragilis Infection

Part of Digestive system, Infections clinical trials.

This trial tests if paromomycin or metronidazole works better for adults with ongoing stomach problems caused by a parasite called Dientamoeba fragilis. These symptoms (pain, bloating, diarrhea) must have lasted more than a month, and no other cause has been found.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have had stomach or gut symptoms (like pain, bloating, or diarrhea) for more than a month
  • A stool test confirmed you have Dientamoeba fragilis and no other infection (except Blastocystis hominis is okay)
  • Your symptoms are not explained by another medical condition
  • You are not pregnant
  • You have not taken metronidazole or paromomycin in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07120490Not yet recruiting
Comparing treatments for C. diff infection to stop it from returning

This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.

NCT06794944Not yet recruiting· Phase 4
Comparing two antibiotics to clear C. difficile in inflammatory bowel disease

This study tests two antibiotics—fidaxomicin and vancomycin—to see which is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease. If you are having a colonoscopy, you may be able to participate.

Boston, Massachusetts
NCT07258173Not yet recruiting· Phase 2
Comparing two deworming medicines for whipworm infection

This study tests a single dose of a new medicine, emodepside, against a standard deworming medicine, albendazole, for treating whipworm infections. It aims to see which is more effective and safe.

NCT05835206Recruiting· Phase 2
Drug to reduce antibiotic-resistant gut bacteria

This Phase 2 study tests whether an investigational treatment can help clear or reduce antibiotic-resistant bacteria living in the gut. It may help prevent these germs from causing future infections by targeting specific resistant bacteria found on stool or rectal swabs.

Atlanta, Georgia
NCT07524920Not yet recruiting· Phase 2
Comparing two antibiotic combinations for drug-resistant infections

This study tests which of two antibiotic combinations works better at clearing infections caused by multi-drug-resistant bacteria in adults, including those with weakened immune systems. It aims to find a more effective treatment option.

Cairo
NCT07746934Not yet recruiting
Comparing two antibiotic treatments for H. pylori infection

This study compares two different antibiotic combinations (metronidazole vs. tinidazole, both with bismuth and other medicines) to see which works better at getting rid of H. pylori, a bacteria that can cause stomach ulcers. If you have H. pylori and haven't been treated before, you may be able to help us find the best option.

Ho Chi Minh City, Ho Chi Minh

Hear when a new Dientamoeba Fragilis Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.